DCGO DocGo Inc.

Nasdaq docgo.com


$ 1.06 $ 0.00 (0 %)    

Monday, 17-Nov-2025 04:24:19 EST
QQQ $ 609.96 $ 0.00 (0 %)
DIA $ 471.53 $ 0.00 (0 %)
SPY $ 672.34 $ 0.00 (0 %)
TLT $ 89.33 $ 0.00 (0 %)
GLD $ 375.39 $ 0.00 (0 %)
$ 1.07
$ 1.01
$ 1.05 x 30
$ 1.12 x 5,590
-- - --
$ 0.97 - $ 5.68
910,347
na
104.66M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-14-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-15-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 06-03-2021 03-31-2021 10-Q
20 03-30-2021 12-31-2020 10-K
21 11-25-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 correction-docgo-q3-adj-eps-011-beats-012-estimate-sales-70810m-beat-69770m-estimate

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 5.17...

 docgo-narrows-fy2025-sales-guidance-from-300000m-330000m-to-315000m-320000m-vs-317559m-est

DocGo (NASDAQ:DCGO) narrows FY2025 sales outlook from $300.000 million-$330.000 million to $315.000 million-$320.000 million vs...

 docgo-plans-to-roll-out-longitudinal-care-services-in-q4-in-collaboration-with-california-based-insurance-provider

DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health an...

 docgo-acquires-virtual-care-platform-steadymd-no-financial-terms-disclosed-in-2025-steadymd-is-expected-to-generate-25m-in-revenue-and-is-expected-to-be-ebitda-positive-for-2026

Strategic Acquisition Combines DocGo's Last Mile Healthcare Delivery Capabilities With SteadyMD's Virtual Care Platform...

 canaccord-genuity-maintains-hold-on-docgo-raises-price-target-to-16

Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Hold and raises the price target from $1.45 to ...

 docgo-affirms-fy2025-sales-guidance-of-300000m-330000m-vs-314472m-est

DocGo (NASDAQ:DCGO) affirms FY2025 sales outlook from $300.000 million-$330.000 million to $300.000 million-$330.000 million vs...

 docgo-q2-eps-011-misses-009-estimate-sales-80418m-beat-77569m-estimate

DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 17...

 docgo-extends-share-repurchase-program-to-december-31-2025

-SEC Filing

 canaccord-genuity-downgrades-docgo-to-hold-lowers-price-target-to-145

Canaccord Genuity analyst Richard Close downgrades DocGo (NASDAQ:DCGO) from Buy to Hold and lowers the price target from $5 ...

 needham-maintains-buy-on-docgo-lowers-price-target-to-3

Needham analyst Ryan MacDonald maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $4 to $3.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION